  |
|||||||||||||||
  |
|||||||||||||||
  |
|||||||||||||||
|
Press Conference Media Material, March 5th, 2004
- Efficacy and safety of recombinant activated Factor VII (rFVIIa) in the treatment of bleeding in severely injured trauma patients
- Efficacy and safety of recombinant activated Factor VII (rFVIIa) in the treatment of bleeding in severely injured trauma subjects (Study 2159), Background Information
- Recombinant activated Factor VII (rFVIIa), Mode of Action, Background Information
- Trauma, Background Information
- Novo Nordisk, Background Information